Corona Remedies IPO Reservation
The Corona Remedies IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 45,71,882 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.
The Retail Individual Investor (RII) category has the highest allocation with 22,55,281 shares, representing 49.33% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 12,88,732 shares (28.19%), while Non-Institutional Investors (NIIs) receive 9,66,549 shares (21.14%). The NII portion is further divided into Big Non-Institutional Investors (BNII) with 6,44,366 shares (14.09%) and Small Non-Institutional Investors (SNII) with 3,22,183 shares (7.05%).
The IPO also includes a dedicated reservation for Employees, comprising 61,320 shares (1.34%). This category-wise reservation provides a clear view of how the IPO shares are distributed among eligible investor groups.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 1288732 | 28.19 | 0 |
| Non-Institutional | 966549 | 21.14 | 0 |
| BNII | 644366 | 14.09 | 0 |
| SNII | 322183 | 7.05 | 0 |
| Retail Investors | 2255281 | 49.33 | 0 |
| Employees | 61320 | 1.34 | 0 |
| Total | 4571882 | 100 | 0 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the retail investor quota in the Corona Remedies IPO?
The Retail Individual Investor (RII) quota in the Corona Remedies IPO comprises 22,55,281 equity shares, representing 49.33% of the total IPO issue.
What is the reservation for QIBs in the Corona Remedies IPO?
Qualified Institutional Buyers (QIBs) have been allocated 12,88,732 equity shares, representing 28.19% of the total IPO issue.
What is the reservation for HNI investors in the Corona Remedies IPO?
The Non-Institutional Investors (NII) category has been allotted 9,66,549 equity shares (21.14%). This category is further divided into: Big HNI (bNII): 3,22,183 shares (14.09%) Small HNI (sNII): 6,44,366 shares (7.05%).
What is the category-wise reservation in the Corona Remedies IPO?
The Corona Remedies IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 12,88,732 shares (28.19%). Non-Institutional Investors (NII): 9,66,549 shares (21.14%). Retail Individual Investors (RII): 22,55,281 shares (49.33%). Employees: 61,320 shares (1.34%).
Is there an employee reservation in the Corona Remedies IPO?
Yes. The Corona Remedies IPO has reserved 61,320 equity shares, representing 1.34% of the total issue for eligible employees.
Is there a shareholder quota in the Corona Remedies IPO?
No. The Corona Remedies IPO does not include a shareholder reservation.